Syndax Pharmaceuticals, Inc. (SNDX)
24.23
+0.42
(+1.76%)
USD |
NASDAQ |
Apr 17, 16:00
24.20
-0.02
(-0.10%)
After-Hours: 20:00
Syndax Pharmaceuticals SG&A Expense (Quarterly) : 49.93M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | 23.93M |
| Vera Therapeutics, Inc. | 34.90M |
| Biogen, Inc. | 682.50M |
| Johnson & Johnson | 0.00 |
| Tango Therapeutics, Inc. | 9.763M |